These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 33497541
1. Von Willebrand disease type 2N: An update. Seidizadeh O, Peyvandi F, Mannucci PM. J Thromb Haemost; 2021 Apr; 19(4):909-916. PubMed ID: 33497541 [Abstract] [Full Text] [Related]
2. Laboratory Testing for von Willebrand Factor: Factor VIII Binding for the Diagnosis or Exclusion of Type 2N von Willebrand Disease: An Update. Favaloro EJ, Mohammed S, Vong R, Pasalic L. Methods Mol Biol; 2023 Apr; 2663():679-691. PubMed ID: 37204745 [Abstract] [Full Text] [Related]
3. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor. Miller CH, Kelley L, Green D. Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396 [Abstract] [Full Text] [Related]
4. Validation of the first commercial ELISA for type 2N von Willebrand's disease diagnosis. Veyradier A, Caron C, Ternisien C, Wolf M, Trossaert M, Fressinaud E, Goudemand J. Haemophilia; 2011 Nov; 17(6):944-51. PubMed ID: 21371195 [Abstract] [Full Text] [Related]
5. Type 2N von Willebrand disease: Characterization and diagnostic difficulties. Casonato A, Galletta E, Sarolo L, Daidone V. Haemophilia; 2018 Jan; 24(1):134-140. PubMed ID: 29115006 [Abstract] [Full Text] [Related]
6. Similarity in joint and mucous bleeding syndromes in type 2N von Willebrand disease and severe hemophilia A coexisting with type 1 von Willebrand disease in two Chinese pedigrees. Qin HH, Xing ZF, Wang XF, Ding QL, Xi XD, Wang HL. Blood Cells Mol Dis; 2014 Apr; 52(4):181-5. PubMed ID: 24351655 [Abstract] [Full Text] [Related]
7. Evaluation of von Willebrand factor phenotypes and genotypes in Hemophilia A patients with and without identified F8 mutations. Boylan B, Rice AS, De Staercke C, Eyster ME, Yaish HM, Knoll CM, Bean CJ, Miller CH, Hemophilia Inhibitor Research Study Investigators. J Thromb Haemost; 2015 Jun; 13(6):1036-42. PubMed ID: 25780857 [Abstract] [Full Text] [Related]
8. Are Iranian patients with von Willebrand disease type 2N properly differentiated from hemophilia A and do they receive appropriate treatment? Seidi Zadeh O, Ahmadinejad M, Amoohossein B, Homayoun S. Blood Coagul Fibrinolysis; 2020 Sep; 31(6):382-386. PubMed ID: 32815913 [Abstract] [Full Text] [Related]
9. Abnormal von Willebrand factor secretion, factor VIII stabilization and thrombus dynamics in type 2N von Willebrand disease mice. Swystun LL, Georgescu I, Mewburn J, Deforest M, Nesbitt K, Hebert K, Dwyer C, Brown C, Notley C, Lillicrap D. J Thromb Haemost; 2017 Aug; 15(8):1607-1619. PubMed ID: 28581694 [Abstract] [Full Text] [Related]
10. The Lesson Learned from the New c.2547-1G > T Mutation Combined with p.R854Q: When a Type 2N Mutation Reveals a Quantitative von Willebrand Factor Defect. Casonato A, Cozzi MR, Ferrari S, Rubin B, Gianesello L, De Marco L, Daidone V. Thromb Haemost; 2022 Sep; 122(9):1479-1485. PubMed ID: 35189660 [Abstract] [Full Text] [Related]
11. Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project. Pérez-Rodríguez A, Batlle J, Pinto JC, Corrales I, Borràs N, Garcia-Martínez I, Cid AR, Bonanad S, Parra R, Mingot-Castellano ME, Navarro N, Altisent C, Pérez-Montes R, Moretó A, Herrero S, Soto I, Mosteirín NF, Jiménez-Yuste V, Jacob AA, Fontanes E, Mateo J, Quismondo NC, Batlle F, Vidal F, López-Fernández MF, investigators and centers involved in the PCM-EVW-ES projectComplexo Hospitalario Universitario A Coruña, INIBIC, A Coruña, Spain.. Haemophilia; 2021 Nov; 27(6):1007-1021. PubMed ID: 34494337 [Abstract] [Full Text] [Related]
12. Laboratory diagnosis and molecular classification of von Willebrand disease. Gadisseur A, Hermans C, Berneman Z, Schroyens W, Deckmyn H, Michiels JJ. Acta Haematol; 2009 Nov; 121(2-3):71-84. PubMed ID: 19506352 [Abstract] [Full Text] [Related]
13. Recessive von Willebrand disease type 2 Normandy: variable expression of mild hemophilia and VWD type 1. Michiels JJ, Gadisseur A, Vangenegten I, Schroyens W, Berneman Z. Acta Haematol; 2009 Nov; 121(2-3):119-27. PubMed ID: 19506358 [Abstract] [Full Text] [Related]
14. Factor VIII-von Willebrand factor binding defects in autosomal recessive von Willebrand disease type Normandy and in mild hemophilia A. New insights into factor VIII-von Willebrand factor interactions. Jacquemin M. Acta Haematol; 2009 Nov; 121(2-3):102-5. PubMed ID: 19506355 [Abstract] [Full Text] [Related]
15. Laboratory diagnosis of von Willebrand disease type 1/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide/antigen ratio. Gadisseur A, Berneman Z, Schroyens W, Michiels JJ. Acta Haematol; 2009 Nov; 121(2-3):128-38. PubMed ID: 19506359 [Abstract] [Full Text] [Related]
16. Laboratory Testing for von Willebrand Factor: Factor VIII Binding (for 2N VWD). Mohammed S, Favaloro EJ. Methods Mol Biol; 2017 Nov; 1646():461-472. PubMed ID: 28804848 [Abstract] [Full Text] [Related]
17. Type 2N von Willebrand disease due to compound heterozygosity for R854Q and a novel R763G mutation at the cleavage site of von Willebrand factor propeptide. Hilbert L, Nurden P, Caron C, Nurden AT, Goudemand J, Meyer D, Fressinaud E, Mazurier C, INSERM Network on Molecular Abnormalities in von Willebrand Disease. Thromb Haemost; 2006 Sep; 96(3):290-4. PubMed ID: 16953269 [Abstract] [Full Text] [Related]
18. Type 2N von Willebrand disease. Mazurier C, Hilbert L. Curr Hematol Rep; 2005 Sep; 4(5):350-8. PubMed ID: 16131435 [Abstract] [Full Text] [Related]
19. Next-generation sequencing of von Willebrand factor and coagulation factor VIII genes: a cross-sectional study in Croatian adult patients diagnosed with von Willebrand disease. Lapić I, Radić Antolic M, Boban A, Coen Herak D, Rogić D, Zadro R. Croat Med J; 2022 Apr 30; 63(2):166-175. PubMed ID: 35505650 [Abstract] [Full Text] [Related]
20. Clinical phenotype in genetically confirmed von Willebrand disease type 2N patients reflects a haemophilia A phenotype. van Meegeren ME, Mancini TL, Schoormans SC, van Haren BJ, van Duren C, Diekstra A, Laros-van Gorkom BA, Brons PP, Simons A, Hoefsloot L, van Heerde WL. Haemophilia; 2015 Sep 30; 21(5):e375-83. PubMed ID: 26207643 [Abstract] [Full Text] [Related] Page: [Next] [New Search]